21 CFR 556.34
§ 556.34 Albendazole.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 556.34, § 556.34 Albendazole, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87732
- Permanent ID
ys:prov:87732@1- SHA-256
8b44c49027347eecd3b7fa6bd389a764614e621c3d4134a011214cf37b84abeb
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Acceptable daily intake (ADI). The ADI for total residue of albendazole is 5 µg/kg of body weight per day.
(b) Tolerances. The tolerances for albendazole 2-aminosulfone (marker residue) are:
(1) Cattle.
(i) Liver (target tissue): 0.2 ppm.
(ii) Muscle: 0.05 ppm.
(2) Sheep.
(i) Liver (target tissue): 0.25 ppm.
(ii) Muscle: 0.05 ppm.
(3) Goat.
(i) Liver (target tissue): 0.25 ppm.
(ii) [Reserved]
(c) Related conditions of use. See §§ 520.38a and 520.38b of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.